Valproate
Valproic acid
- Category
- pharmaceutical · Antiseizure medication
- Record
- specific compound · in current use
- Identifiers
- CAS 99-66-1
- Aliases
- Sodium valproate, Valproic acid
Antiseizure medication. Developmental toxicity is established and is largely not specifically endocrine. Metabolic and mitochondrial signals are recorded separately.
Flags: pharmaceutical
Phase-1 numbers are seed hypotheses. They are not curated consensus, not a toxicity total, and not a statement of human risk. Association is not written as causation.
| Context | Life stage | Type | Dose metric | Real-world relevance |
|---|---|---|---|---|
Adults prescribed valproate Therapeutic dose. | adult | therapeutic | prescribed dose | high |
Pregnant patients prescribed valproate Gestational therapeutic exposure. The developmental outcome is not an overdose claim. | pregnancy | therapeutic · maternal | prescribed dose | high |